Effect of race on transplant outcome and response to OKT3 monoclonal antibody therapy.
First
M R
MR
University of Cincinnati Medical Center, OH 45267-0585.
Schroeder
T J
TJ
Carey
M A
MA
Chavinson
D S
DS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D044383:Black People; D017252:CD3 Complex; D015704:CD4 Antigens / Q000032:analysis; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D044469:Racial Groups; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D016019:Survival Analysis; D044465:White People
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D015704:CD4 Antigens; D011948:Receptors, Antigen, T-Cell